Detalhe da pesquisa
1.
P-TEFb promotes cell survival upon p53 activation by suppressing intrinsic apoptosis pathway.
Nucleic Acids Res
; 51(4): 1687-1706, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727434
2.
Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response data.
Nucleic Acids Res
; 51(W1): W57-W61, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178002
3.
Breeze: an integrated quality control and data analysis application for high-throughput drug screening.
Bioinformatics
; 36(11): 3602-3604, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32119072
4.
ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitors.
J Pathol
; 250(2): 159-169, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31595974
5.
Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas.
Br J Cancer
; 120(4): 435-443, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30745580
6.
Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma.
BMC Cancer
; 19(1): 628, 2019 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31238897
7.
Robust scoring of selective drug responses for patient-tailored therapy selection.
Nat Protoc
; 19(1): 60-82, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37996540
8.
Characterisation of new in vitro models and identification of potentially active drugs in angiosarcoma.
Biomed Pharmacother
; 173: 116397, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38479181
9.
Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemia.
Cell Rep Med
; 5(5): 101521, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38653245
10.
Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome.
Antiviral Res
; 223: 105813, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38272320
11.
Protocol for 3D drug sensitivity and resistance testing of patient-derived cancer cells in 384-well plates.
SLAS Discov
; 28(2): 36-41, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36464160
12.
Comparison of two supporting matrices for patient-derived cancer cells in 3D drug sensitivity and resistance testing assay (3D-DSRT).
SLAS Discov
; 28(4): 138-148, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36934951
13.
Drug repositioning strategy for the identification of novel telomere-damaging agents: A role for NAMPT inhibitors.
Aging Cell
; 22(11): e13944, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37858982
14.
Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets.
Eur Urol Focus
; 9(5): 751-759, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36933996
15.
Image-based and machine learning-guided multiplexed serology test for SARS-CoV-2.
Cell Rep Methods
; 3(8): 100565, 2023 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671026
16.
Genome-wide siRNA screening reveals several host receptors for the binding of human gut commensal Bifidobacterium bifidum.
NPJ Biofilms Microbiomes
; 8(1): 50, 2022 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35768415
17.
Functional temozolomide sensitivity testing of patient-specific glioblastoma stem cell cultures is predictive of clinical outcome.
Transl Oncol
; 26: 101535, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36115076
18.
Targeting Apoptosis Pathways With BCL2 and MDM2 Inhibitors in Adult B-cell Acute Lymphoblastic Leukemia.
Hemasphere
; 6(3): e701, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35233509
19.
Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status.
Front Oncol
; 12: 954430, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36081565
20.
Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia.
Cancer Discov
; 12(2): 388-401, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34789538